This is a firm fixed-price purchase order contract awarded by the Medical Supply Chain organization of the Defense Department to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract, valued at $6,614.55, is for the delivery of a FilmArray NGDS (Next Generation Diagnostic System) Warr (Warranty). The contract has no set-aside designation and has a completion date of November 7, 2024. Biofire Defense has previously been awarded federal prime contracts, subcontracts, and grants related to biological threat detection, infectious disease testing, and COVID-19 response, including a $6.2 million cooperative agreement to expand manufacturing capacity for Department of Defense COVID test kits. The company also holds a larger $18.8 million indefinite delivery contract from the Army's Acquisition Support Center Chemical and Biological Defense organization for sustainment of the Next Generation Diagnostic System.
Generated 1/7/25, 11:46 AM